J. Michael Delmage, Executive MBA ’87

Michael has been Michael Delmageappointed CEO of ProGDerm, a biotechnology company specializing in research in skin rejuvenation and anti-aging. He brings with him over 25 years of experience in the pharmaceutical, biotechnology and medical device industries. Most recently, Michael served as president and CEO of Transvivo Inc., manufacturer of the Omni-DL system, a portable dialysis system. He also served as chief technology officer of Senetek PLC, a skincare and pharmaceutical business, and was a founding executive at pharmaceutical firm Santen International.

J. Michael Delmage, Executive MBA ’87

Read About These Alumni:

Tagged on:         

Leave a Reply